Peer-influenced content. Sources you trust. No registration required. This is HCN.

Psychiatrist.comLost in Translation: The Value of Psychiatric Clinical Trials

After supporting a number of significant clinical trials in psychiatry more than ten years ago, NIMH abruptly shifted its approach and began allocating 90% of its money to neuroscience. The policy is still in place even though this “has yet to deliver major clinical gains.” Clinical advancement has been halted as a result of the devaluation of mental clinical trials and the meticulously designed, essential methodologies they demand.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form